The Impact of Orthopaedic Smoking Cessation Education on Cigarette Abstinence Self-Efficacy: A Randomized Controlled Trial

NCT ID: NCT02408809

Last Updated: 2017-06-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-03-31

Study Completion Date

2016-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators of this study aim to evaluate the impact of a new orthopaedic related smoking cessation discussion on smoking behavior. Considering the high prevalence of patients who smoke and receive orthopaedic management, we are interested in determining whether an orthopaedic smoking cessation discussion impacts smoking abstinence self-efficacy over time compared to a general smoking cessation discussion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cigarette Smoking

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Group Type ACTIVE_COMPARATOR

General Smoking Cessation Discussion

Intervention Type BEHAVIORAL

This group receives the 5 A's of smoking cessation counseling incorporating how cigarette smoking negatively impacts general health (cancer, MI). 10 minutes in length.

Intervention

Group Type ACTIVE_COMPARATOR

Orthopaedic Related Smoking Cessation Discussion

Intervention Type BEHAVIORAL

The participants in this group receive a discussion including the 5 A's of smoking cessation counseling incorporating an orthopaedic related smoking cessation discussion about the effects of smoking cigarettes on the musculoskeletal system. 10 minutes in length.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

General Smoking Cessation Discussion

This group receives the 5 A's of smoking cessation counseling incorporating how cigarette smoking negatively impacts general health (cancer, MI). 10 minutes in length.

Intervention Type BEHAVIORAL

Orthopaedic Related Smoking Cessation Discussion

The participants in this group receive a discussion including the 5 A's of smoking cessation counseling incorporating an orthopaedic related smoking cessation discussion about the effects of smoking cigarettes on the musculoskeletal system. 10 minutes in length.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Daily cigarette smokers (5 cigarettes or more a day for past year), 18 years of age or older, new orthopaedic management, native English speaker

Exclusion Criteria

* Patients unable to provide consent, suffer an impairment (mental, psychiatric, hearing or sight), alcohol and illicit drug abusers, homeless, presently managed with a smoking cessation medication or counseling, living with a cigarette smoker, user of other tobacco products
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Missouri, Kansas City

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nkemakolam Egekeze

Orthopaedic Surgery Researcher

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nkem Egekeze, MD

Role: PRINCIPAL_INVESTIGATOR

UMKC DEPT OF ORTHOPAEDIC SURGERY

Akin Cil, MD

Role: STUDY_DIRECTOR

UMKC DEPT OF ORTHOPAEDIC SURGERY

Karen Williams, PhD

Role: STUDY_DIRECTOR

UMKC DEPT OF BIOINFORMATICS

James Bogener, MD

Role: STUDY_DIRECTOR

UMKC DEPT OF ORTHOPAEDIC SURGERY

Mark Bernhardt, MD

Role: STUDY_DIRECTOR

UMKC DEPT OF ORTHOPAEDIC SURGERY

Jonathan Dubin, MD

Role: STUDY_DIRECTOR

UMKC DEPT OF ORTHOPAEDIC SURGERY

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

15-247

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Smoking Cessation Study
NCT05602753 UNKNOWN
Smoking Cessation Intervention
NCT03072511 TERMINATED PHASE4